If your insurance does not cover GLP-1 weight loss medications — or you do not have insurance at all — the sticker shock is real. Brand-name Wegovy runs $1,300+/month. Brand Zepbound is $1,060+/month. That is $12,000–$15,000 per year, which is unrealistic for most people paying cash. But the 2026 market has created options that did not exist even two years ago. Here is how to access effective weight loss treatment without insurance at prices that do not require a second mortgage.
Quick Answer
The most affordable GLP-1 weight loss option without insurance in 2026 is compounded semaglutide through a reputable telehealth provider ($149–$399/month). Foundayo (orforglipron) is the best brand-name value at ~$149–$299/month. Manufacturer savings programs, patient assistance programs, and GoodRx can reduce costs on brand-name medications. Non-GLP-1 options like naltrexone/bupropion and phentermine are the cheapest prescription alternatives.
Affordable Weight Loss Options Without Insurance
| Option | Monthly Cost | Effectiveness | Accessibility | Best For |
|---|---|---|---|---|
| Compounded Semaglutide | $149–$399 | High (same active ingredient as Wegovy) | Widely available via telehealth | Best overall value for GLP-1 |
| Foundayo (Orforglipron) | $149–$299 | High (oral GLP-1, no injections) | Growing availability | Brand-name at accessible price |
| Brand Wegovy + Savings Card | $0–$500 (varies) | Very high | Requires commercial insurance | If you have any commercial plan |
| Brand Zepbound + Savings Card | $0–$550 (varies) | Very high | Requires commercial insurance | If you have any commercial plan |
| GoodRx + Retail Pharmacy | $700–$1,000 (discounted) | Very high | Any retail pharmacy | Moderate savings on brand-name |
| Patient Assistance Programs | $0 (if eligible) | Very high | Income-based eligibility | Low-income uninsured patients |
| Naltrexone/Bupropion (Contrave generic) | $30–$80 | Moderate (5–8% weight loss) | Widely available | Cheapest prescription option |
| Phentermine | $15–$40 | Moderate (short-term) | Widely available | Very short-term use only |
Option 1: Compounded Semaglutide — Best Overall Value
Compounded semaglutide is the same active ingredient (semaglutide) as Wegovy and Ozempic, but produced by compounding pharmacies rather than Novo Nordisk. It costs a fraction of the brand-name price.
What You Need to Know
- Pricing: $149–$399/month depending on dose and provider
- How it works: A telehealth provider prescribes semaglutide, which is filled by a compounding pharmacy and shipped to your home
- Effectiveness: Same active ingredient, same mechanism. Weight loss results should be similar to brand-name products at equivalent doses
- Safety considerations: Quality depends on the compounding pharmacy. Look for providers that use 503B outsourcing facilities (FDA-inspected) rather than traditional 503A pharmacies
- Regulatory status: Compounded semaglutide is legal when Wegovy is on the FDA drug shortage list. If the shortage resolves, availability may change
Top Compounded Semaglutide Providers
- Hims/Hers: Competitive pricing, strong brand, fast shipping (~$149–$399/month)
- Ro: Broad options, at-home labs, insurance integration where applicable (~$149–$499/month)
- Found: Coaching included, metabolic approach (~$129–$449/month)
- MEDVi: Budget option (~$99–$349/month)
- SkinnyRx: Lower-cost basic access (~$89–$299/month)
Option 2: Foundayo — Best Brand-Name Value
Foundayo (orforglipron) is the game-changer for uninsured patients seeking a brand-name GLP-1. Unlike Wegovy ($1,300/month) or Zepbound ($1,060/month), Foundayo launched with a dramatically lower price point.
Why Foundayo Matters for Uninsured Patients
- Pricing: Starting at approximately $149–$299/month — competitive with compounded options
- FDA-approved: Unlike compounded products, Foundayo is an FDA-approved brand-name medication
- Oral tablet: No injections required, no cold-chain shipping, no needle disposal
- No fasting requirement: Take it any time, with or without food
- Weight loss: ~11–12% in clinical trials — meaningful results
Foundayo is available through telehealth providers like Ro and is increasingly offered through retail pharmacies with manufacturer pricing programs.
Option 3: Manufacturer Savings Programs
If you have any commercial insurance (even if it does not cover GLP-1s specifically), manufacturer savings programs can dramatically reduce costs:
Novo Nordisk (Wegovy, Ozempic)
- Wegovy Savings Offer: Eligible commercially insured patients may pay reduced copays
- NovoCare Patient Assistance Program: Free medication for uninsured patients who meet income criteria (typically ≤400% FPL)
- Eligibility: Must not have government insurance (Medicare, Medicaid)
Eli Lilly (Zepbound)
- Zepbound Savings Card: Eligible patients may pay as little as $25/month with commercial insurance
- Lilly Cares Patient Assistance: Free medication for qualifying low-income uninsured patients
- Lilly Direct: Direct purchase options with transparent pricing
How to Apply
- Visit the manufacturer's patient assistance website
- Complete the application (income documentation required)
- Your physician may need to submit a prescription and attestation
- If approved, medication is shipped directly to you or your physician's office — typically at no cost
Option 4: GoodRx and Pharmacy Discount Cards
GoodRx and similar discount platforms negotiate lower prices at retail pharmacies:
- Typical GoodRx pricing (2026): Wegovy ~$900–$1,000/month; Ozempic ~$800–$900/month; Zepbound ~$850–$950/month
- Savings: Usually 15–30% off list price
- How it works: Search the medication on GoodRx, get a coupon, present at the pharmacy counter
- Best use case: Moderate savings on brand-name medications when other options are not available
- Reality check: Even with GoodRx, brand-name GLP-1s remain expensive. This option is best combined with other strategies or used as a bridge
Option 5: Non-GLP-1 Weight Loss Medications
If GLP-1s are financially out of reach even at compounded prices, there are less expensive prescription alternatives:
Naltrexone/Bupropion (Generic Contrave)
- Cost: $30–$80/month for generic
- Weight loss: 5–8% average — less than GLP-1s but meaningful
- Mechanism: Reduces cravings and appetite through different pathways than GLP-1s
- Good for: Patients with emotional or binge eating patterns
Phentermine
- Cost: $15–$40/month (generic)
- Weight loss: 5–10% short-term
- Limitation: FDA-approved for short-term use only (typically 12 weeks)
- Good for: Kickstarting weight loss before transitioning to a longer-term approach
Topiramate + Phentermine (Qsymia or Generic Components)
- Cost: $50–$120/month
- Weight loss: 8–10% — closer to GLP-1 territory
- Note: More side effects (cognitive effects, tingling) than GLP-1s
Building Your Affordable Weight Loss Plan
Here is a practical decision framework for patients without insurance coverage:
- Check patient assistance first: If your household income is below 400% of the Federal Poverty Level, apply for manufacturer PAPs. Free medication is the best price.
- Consider Foundayo: At $149–$299/month for an FDA-approved oral GLP-1, it is the best brand-name value in the market.
- Evaluate compounded semaglutide: If Foundayo is not available or you prefer an injectable option, compounded semaglutide through a reputable provider is the next best value.
- Non-GLP-1 as backup: If GLP-1s are not financially viable, naltrexone/bupropion at $30–$80/month is a legitimate alternative with real (if more modest) results.
- Stack strategies: Some patients use phentermine short-term while applying for PAPs or waiting for Foundayo access.
Red Flags to Avoid
- "Too cheap" compounded GLP-1: If a provider offers semaglutide for $29/month, question the quality and source
- No medical consultation: Legitimate programs require a provider evaluation, even if it is asynchronous
- Unverified pharmacies: Insist on 503B outsourcing facilities for compounded medications
- Peptide "alternatives": Products marketed as "similar to semaglutide" that contain research peptides or non-FDA-regulated compounds
- International pharmacy imports: While tempting due to lower prices, importing prescription medications is illegal and quality is unverifiable
Bottom Line
No insurance coverage does not mean no options. Compounded semaglutide and Foundayo have made GLP-1 weight loss accessible at $149–$399/month. Patient assistance programs provide free brand-name medication for qualifying patients. Non-GLP-1 alternatives exist at $30–$80/month. The key is choosing a reputable provider, understanding what you are getting, and avoiding the bottom-of-the-barrel options that cut corners on quality and safety.
MedSwitcher helps you compare cash-pay pricing across providers, check patient assistance eligibility, and find the most affordable path to effective weight loss treatment — with or without insurance.
Sources
- Manufacturer patient assistance program details (Novo Nordisk NovoCare, Eli Lilly Cares), 2026.
- GoodRx pricing data, verified April 2026.
- FDA compounding pharmacy regulatory guidance.
- Telehealth provider pricing, verified April 2026.
- MedSwitcher pricing comparison database, updated April 2026.